| Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain R Chou, GJ Fanciullo, PG Fine, JA Adler, JC Ballantyne, P Davies, ... The journal of pain 10 (2), 113-130. e22, 2009 | 2736 | 2009 |
| American Pain Society–American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain R Chou, GJ Fanciullo, PG Fine, JA Adler, JC Ballantyne, P Davies, ... J Pain 10 (2), 113-130, 2009 | 285 | 2009 |
| Understanding buprenorphine for use in chronic pain: expert opinion L Webster, J Gudin, RB Raffa, J Kuchera, R Rauck, J Fudin, J Adler, ... Pain Medicine 21 (4), 714-723, 2020 | 107 | 2020 |
| Rational urine drug monitoring in patients receiving opioids for chronic pain: consensus recommendations CE Argoff, DP Alford, J Fudin, JA Adler, MJ Bair, RC Dart, R Gandolfi, ... Pain Medicine 19 (1), 97-117, 2018 | 86 | 2018 |
| An overview of abuse-deterrent opioids and recommendations for practical patient care JA Adler, T Mallick-Searle Journal of multidisciplinary healthcare, 323-332, 2018 | 28 | 2018 |
| Intrathecal pain management: a team-based approach JA Adler, NM Lotz Journal of Pain Research, 2565-2575, 2017 | 24 | 2017 |
| Update on Treating Painful Diabetic Peripheral Neuropathy: A Review of Current US Guidelines with a Focus on the Most Recently Approved Management Options T Mallick-Searle, JA Adler Journal of Pain Research, 1005-1028, 2024 | 6 | 2024 |
| Updates on managing acute and chronic pain in primary care practice--optimizing pain reduction, minimizing adverse events BH McCarberg, JA Adler JAAPA: official journal of the American Academy of Physician Assistants, 1-13, 2008 | 2 | 2008 |
| Once-Daily Cyclobenzaprine Extended-Release for Acute Muscle Spasm. JA Adler Clinician Reviews 21 (5), 2011 | 1 | 2011 |
| Frontline Perspectives on Buprenorphine for the Management of Chronic Pain J Adler, T Mallick-Searle, M Garofoli, A Zimmerman Journal of Multidisciplinary Healthcare, 1375-1383, 2024 | | 2024 |
| Efficacy and Safety of Naloxegol in Patients with Chronic Non-Cancer Pain Who Experience Opioid-Induced Constipation: A Pooled Analysis of Two Global, Randomized Controlled Studies WD Chey, DM Brenner, BD Cash, M Hale, J Adler, MS Jamindar, ... Journal of Pain Research, 2943-2953, 2023 | | 2023 |
| S497 Naloxegol Accelerates Time to First Spontaneous Bowel Movement (SBM) and Complete SBM (CSBM) With Predictable Efficacy in Patients With Extreme Opioid-Induced Constipation … WD Chey, DM Brenner, J Adler, T Mallick-Searle, C Rockett, E Bortey Official journal of the American College of Gastroenterology| ACG 116, S221, 2021 | | 2021 |
| S508 Naloxegol Achieved Rapid and Sustained Improvement of Opioid-Induced Constipation (OIC) Symptoms in Patients With Extreme OIC: A Pooled Analysis of Two Pivotal Phase 3 Trials DM Brenner, WD Chey, J Adler, T Mallick-Searle, E Bortey, C Rockett Official journal of the American College of Gastroenterology| ACG 116, S227, 2021 | | 2021 |
| Efficacy and Safety of Ketamine Infusions versus Opioids in Managing Severe Pain from Complex Regional Pain Syndrome J Adler University of Lynchburg DMSc Doctoral Project Assignment Repository 1 (2), 2, 2019 | | 2019 |
| (396) Effect of gabapentin enacarbil (GEn) on adverse events (AEs) by age group in a randomized, placebo-controlled trial of patients with postherpetic neuralgia (PHN) E Dunteman, M Wallace, J Adler, C Argoff, M Jaros, R Kim, G Shang The Journal of Pain 16 (4), S75, 2015 | | 2015 |
